Previous Page  17 / 23 Next Page
Information
Show Menu
Previous Page 17 / 23 Next Page
Page Background

Page 30

Notes:

allied

academies

Asian Journal of Biomedical and Pharmaceutical Sciences | Volume 8

March 26-27, 2018 | Orlando, USA

World Summit on

Healthcare & Hospital Management

&

International Conference & Exhibition on

Biologics and Biosimilars

Radwan Ahmed

PIONEERA HealthCare Group, Egypt & Herriot Watt University, UK

Biosimilars marketing strategies: Insight into the future of potential

growth and key challenges

W

hat does experience in the Eu and US so far can tell us

about the opportunities and challenges in Biosimilars?

While Biosimilars’ growth potential looks extremely attractive,

winning is not as simple as it might look at the first sight.

Biosimilars hold a great potential for stakeholders. The

opportunities are estimated at approximately $100 billion of

biologics to lose patent protection in the Eu and US over the

next few years. Although the European experience to date is

reasonably good, additional challenges to the new launches of

Biosimilars shouldbeconsidered. Companies shouldcrafta clear

marketing strategy and incorporate the lessons learned from

previous successes and failures. Past events in the biosimilar

global market place could provide valuable insights into future

success. In fact, it could provide an interesting reference for the

next waves of Biosimilars.

Speaker Biography

Radwan Ahmed is the Chairman and CEO of PIONEERA Healthcare Group. He is also

an Adjunct Professor of Management at Edinburgh Business School; Herriot Watt

University in the UK. He has over 25 years of experience within the Pharmaceutical

sector, including ethical pharmaceuticals, OTC, generics and strategic management

consultation. His experience was gained at French, German, Japanese, Swiss and

British multinational pharmaceutical companies. He was the Marketing Director of

Novartis, Regional Marketing Director of Otsuka and GSK. He has received his Master

and Doctoral degrees fromMiddlesex University in London. He also holds a first degree

in Pharmacy and Pharmaceutical Sciences from Cairo University.

e:

ahmed.radwan@pioneerahc.com